218 related articles for article (PubMed ID: 29031692)
1. Development and application of a bioluminescent imaging mouse model for Chikungunya virus based on pseudovirus system.
Wu J; Zhao C; Liu Q; Huang W; Wang Y
Vaccine; 2017 Nov; 35(47):6387-6394. PubMed ID: 29031692
[TBL] [Abstract][Full Text] [Related]
2. Development of a neutralization assay based on the pseudotyped chikungunya virus of a Korean isolate.
Chung WC; Hwang KY; Kang SJ; Kim JO; Song MJ
J Microbiol; 2020 Jan; 58(1):46-53. PubMed ID: 31768937
[TBL] [Abstract][Full Text] [Related]
3. Liposomal Delivery of the RNA Genome of a Live-Attenuated Chikungunya Virus Vaccine Candidate Provides Local, but Not Systemic Protection After One Dose.
Abeyratne E; Tharmarajah K; Freitas JR; Mostafavi H; Mahalingam S; Zaid A; Zaman M; Taylor A
Front Immunol; 2020; 11():304. PubMed ID: 32194557
[TBL] [Abstract][Full Text] [Related]
4. Prime-boost immunization strategies against Chikungunya virus.
Hallengärd D; Lum FM; Kümmerer BM; Lulla A; Lulla V; García-Arriaza J; Fazakerley JK; Roques P; Le Grand R; Merits A; Ng LF; Esteban M; Liljeström P
J Virol; 2014 Nov; 88(22):13333-43. PubMed ID: 25210177
[TBL] [Abstract][Full Text] [Related]
5. Mutation of the N-Terminal Region of Chikungunya Virus Capsid Protein: Implications for Vaccine Design.
Taylor A; Liu X; Zaid A; Goh LY; Hobson-Peters J; Hall RA; Merits A; Mahalingam S
mBio; 2017 Feb; 8(1):. PubMed ID: 28223458
[TBL] [Abstract][Full Text] [Related]
6. An LASV GPC pseudotyped virus based reporter system enables evaluation of vaccines in mice under non-BSL-4 conditions.
Li Q; Liu Q; Huang W; Wu J; Nie J; Wang M; Zhao C; Zhang L; Wang Y
Vaccine; 2017 Sep; 35(38):5172-5178. PubMed ID: 28797730
[TBL] [Abstract][Full Text] [Related]
7. Co-Immunization With CHIKV VLP and DNA Vaccines Induces a Promising Humoral Response in Mice.
Zhao Z; Deng Y; Niu P; Song J; Wang W; Du Y; Huang B; Wang W; Zhang L; Zhao P; Tan W
Front Immunol; 2021; 12():655743. PubMed ID: 33868299
[TBL] [Abstract][Full Text] [Related]
8. Preparation and application of chikungunya pseudovirus containing double reporter genes.
Su C; Ding K; Xu J; Wu J; Liu J; Shen J; Zhou H; Liu H
Sci Rep; 2022 Jun; 12(1):9844. PubMed ID: 35701460
[TBL] [Abstract][Full Text] [Related]
9. Visualization of chikungunya virus infection
Zhang HL; Dong HL; Zhang YN; Xu LL; Deng CL; Li XF; Li XD; Ye HQ; Yuan ZM; Qin CF; Zhang B
Emerg Microbes Infect; 2019; 8(1):1574-1583. PubMed ID: 31682177
[TBL] [Abstract][Full Text] [Related]
10. Pseudotyped Viruses for the Alphavirus Chikungunya Virus.
Wu J; Huang W; Wang Y
Adv Exp Med Biol; 2023; 1407():299-312. PubMed ID: 36920704
[TBL] [Abstract][Full Text] [Related]
11. Infectious Chikungunya Virus (CHIKV) with a Complete Capsid Deletion: a New Approach for a CHIKV Vaccine.
Zhang YN; Deng CL; Li JQ; Li N; Zhang QY; Ye HQ; Yuan ZM; Zhang B
J Virol; 2019 Aug; 93(15):. PubMed ID: 31092567
[TBL] [Abstract][Full Text] [Related]
12. Preparation of vesicular stomatitis virus pseudotype with Chikungunya virus envelope protein.
Tong W; Yin XX; Lee BJ; Li YG
Acta Virol; 2015 Jun; 59(2):189-93. PubMed ID: 26104337
[TBL] [Abstract][Full Text] [Related]
13. DNA vaccine initiates replication of live attenuated chikungunya virus in vitro and elicits protective immune response in mice.
Tretyakova I; Hearn J; Wang E; Weaver S; Pushko P
J Infect Dis; 2014 Jun; 209(12):1882-90. PubMed ID: 24585894
[TBL] [Abstract][Full Text] [Related]
14. A chikungunya fever vaccine utilizing an insect-specific virus platform.
Erasmus JH; Auguste AJ; Kaelber JT; Luo H; Rossi SL; Fenton K; Leal G; Kim DY; Chiu W; Wang T; Frolov I; Nasar F; Weaver SC
Nat Med; 2017 Feb; 23(2):192-199. PubMed ID: 27991917
[TBL] [Abstract][Full Text] [Related]
15. Attenuated and vectored vaccines protect nonhuman primates against Chikungunya virus.
Roques P; Ljungberg K; Kümmerer BM; Gosse L; Dereuddre-Bosquet N; Tchitchek N; Hallengärd D; García-Arriaza J; Meinke A; Esteban M; Merits A; Le Grand R; Liljeström P
JCI Insight; 2017 Mar; 2(6):e83527. PubMed ID: 28352649
[TBL] [Abstract][Full Text] [Related]
16. A bioluminescent imaging mouse model for Marburg virus based on a pseudovirus system.
Zhang L; Li Q; Liu Q; Huang W; Nie J; Wang Y
Hum Vaccin Immunother; 2017 Aug; 13(8):1811-1817. PubMed ID: 28481728
[TBL] [Abstract][Full Text] [Related]
17. Rapid and Long-Term Immunity Elicited by DNA-Encoded Antibody Prophylaxis and DNA Vaccination Against Chikungunya Virus.
Muthumani K; Block P; Flingai S; Muruganantham N; Chaaithanya IK; Tingey C; Wise M; Reuschel EL; Chung C; Muthumani A; Sarangan G; Srikanth P; Khan AS; Vijayachari P; Sardesai NY; Kim JJ; Ugen KE; Weiner DB
J Infect Dis; 2016 Aug; 214(3):369-78. PubMed ID: 27001960
[TBL] [Abstract][Full Text] [Related]
18. Nonstructural protein 2 (nsP2) of Chikungunya virus (CHIKV) enhances protective immunity mediated by a CHIKV envelope protein expressing DNA Vaccine.
Bao H; Ramanathan AA; Kawalakar O; Sundaram SG; Tingey C; Bian CB; Muruganandam N; Vijayachari P; Sardesai NY; Weiner DB; Ugen KE; Muthumani K
Viral Immunol; 2013 Feb; 26(1):75-83. PubMed ID: 23409931
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of recombinant E2 protein-based and whole-virus inactivated candidate vaccines against chikungunya virus.
Kumar M; Sudeep AB; Arankalle VA
Vaccine; 2012 Sep; 30(43):6142-9. PubMed ID: 22884660
[TBL] [Abstract][Full Text] [Related]
20. A DNA vaccine against chikungunya virus is protective in mice and induces neutralizing antibodies in mice and nonhuman primates.
Mallilankaraman K; Shedlock DJ; Bao H; Kawalekar OU; Fagone P; Ramanathan AA; Ferraro B; Stabenow J; Vijayachari P; Sundaram SG; Muruganandam N; Sarangan G; Srikanth P; Khan AS; Lewis MG; Kim JJ; Sardesai NY; Muthumani K; Weiner DB
PLoS Negl Trop Dis; 2011 Jan; 5(1):e928. PubMed ID: 21264351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
